Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine

<p>Abstract</p> <p>The present work aims at preparing aqueous suspension of Solid lipid Nanoparticles containing Chitosan (CT) which is a biopolymer that exhibits a number of interesting properties which include controlled drug delivery. Carbamezapine (CBZ) is a lipophilic drug whi...

Full description

Bibliographic Details
Main Authors: Nair Rahul, Kumar Ashok CK, Priya Vishnu K, Yadav Chakrapani M, Raju Prasanna Y
Format: Article
Language:English
Published: BMC 2012-06-01
Series:Lipids in Health and Disease
Subjects:
Online Access:http://www.lipidworld.com/content/11/1/72
Description
Summary:<p>Abstract</p> <p>The present work aims at preparing aqueous suspension of Solid lipid Nanoparticles containing Chitosan (CT) which is a biopolymer that exhibits a number of interesting properties which include controlled drug delivery. Carbamezapine (CBZ) is a lipophilic drug which shows it antiepileptic activity by inactivating sodium channels. The solid lipid Nanoparticles (SLN) of Chitosan-CBZ were prepared by using solvent injection method using ethanol as organic solvent. The prepared SLN formulations exhibited high encapsulation efficiency, high physical stability. The drug incorporated SLNs have demonstrated that the controlled release patterns of the drug for prolonged period. The prepared SLNs were characterized for surface morphology by SEM analysis, entrapment efficiency, zeta potential, FTIR, DSC and <it>In-vitro</it> diffusion studies. The hydrodynamic mean diameter and zeta potential were 168.7 ±1.8 nm and −28.9 ±2.0 mV for SLN-chitosan-CBZ respectively. Therefore chitosan-SLN can be good candidates to encapsulate CBZ and to increase its therapeutic efficacy in the treatment of Epilepsy.</p>
ISSN:1476-511X